SH

Swen Hoelder

CL Cancer Research Technology Limited: 14 patents #11 of 493Top 3%
SA Sanofi-Aventis: 4 patents #303 of 1,008Top 35%
AS Aventis Pharma S.A.: 3 patents #139 of 591Top 25%
IH Institute Of Cancer Research: Royal Cancer Hospital: 2 patents #33 of 148Top 25%
AG Aventis Pharma Deutschland Gmbh: 1 patents #209 of 418Top 50%
TR The Institute Of Cancer Research: 1 patents #18 of 51Top 40%
Overall (All Time): #191,316 of 4,157,543Top 5%
22
Patents All Time

Issued Patents All Time

Showing 1–22 of 22 patents

Patent #TitleCo-InventorsDate
12110286 Benzimidazolone derived inhibitors of BCL6 Benjamin Richard Bellenie, Michael K. Carter, Kwai Ming Cheung, Owen Alexander Davis, Matthew Garth Lloyd +3 more 2024-10-08
11897877 Inhibitor compounds Julian Blagg, Savade Solanki, Hannah Woodward, Sebastien NAUD, Vassilios Bavetsias +4 more 2024-02-13
11512095 BCL6 inhibitors Benjamin Richard Bellenie, Kwai Ming Cheung, Owen Alexander Davis, Rosemary Huckvale, Gavin Collie +3 more 2022-11-29
11161839 2-quinolone derived inhibitors of BCL6 Benjamin Richard Bellenie, Kwai Ming Cheung, Owen Alexander Davis, Rosemary Huckvale, Matthew Garth Lloyd 2021-11-02
11046688 Inhibitor compounds Julian Blagg, Savade Solanki, Hannah Woodward, Sebastien NAUD, Vassilios Bavetsias +4 more 2021-06-29
10479788 Compounds that inhibit MPS1 kinase Julian Blagg, Savade Solanki, Hannah Woodward, Sebastien NAUD, Vassilios Bavetsias +4 more 2019-11-19
10399974 N2-phenyl-pyrido[3,4-D]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors Hannah Woodward, Paolo Innocenti, Sebastien NAUD, Julian Blagg 2019-09-03
10188642 Pharmacologically active compounds Julian Blagg, Kwai Ming Cheung, Butrus Atrash, Peter Sheldrake 2019-01-29
9902721 N2-phenyl-pyrido[3,4-d]pyrimidine-2, 8-diamine derivatives and their use as Mps1 inhibitors Hannah Woodward, Paolo Innocenti, Sebastien NAUD, Julian Blagg 2018-02-27
9895364 Pharmacologically active compounds Julian Blagg, Kwai Ming Cheung, Butrus Atrash, Peter Sheldrake 2018-02-20
9890157 Inhibitor compounds Julian Blagg, Savade Solanki, Hannah Woodward, Sebastien NAUD, Vassilios Bavetsias +4 more 2018-02-13
9834552 Inhibitor compounds Julian Blagg, Savade Solanki, Hannah Woodward, Sebastien NAUD, Vassilios Bavetsias +4 more 2017-12-05
9409907 Inhibitor compounds Julian Blagg, Savade Solanki, Hannah Woodward, Sebastien NAUD, Vassilios Bavetsias +4 more 2016-08-09
9334286 Pharmacologically active compounds Julian Blagg, Kwai Ming Cheung, Butrus Atrash, Peter Sheldrake 2016-05-10
7968546 Pyridazinone kinase inhibitors Gunter Muller, Karl Schoenafinger, David William Will, Hans Matter, Martin Bossart +5 more 2011-06-28
7754713 4-benzimidazol-2-ylpyridazin-3-one derivatives Karl Schoenafinger, David William Will, Hans Matter, Gunter Muller, Cecile Combeau +3 more 2010-07-13
7727989 4-benzimidazol-2-yl-pyridazine-3-one-derivatives, production and use thereof in medicaments Karl Schoenafinger, David William Will, Hans Matter, Guenter Mueller, Martin Bossart 2010-06-01
7709466 Pyridazinone derivatives, methods for their production and their use as pharmaceuticals Karl Schoenafinger, David William Will, Hans Matter, Guenter Mueller, Martin Bossart 2010-05-04
7507734 Pyridazinone derivatives Gunter Muller, Karl Schoenafinger, David William Will, Hans Matter, Martin Bossart +5 more 2009-03-24
7470689 4-benzimidazol-2-ylpyridazin-3-one derivatives Karl Schoenafinger, David William Will, Hans Matter, Gunter Muller, Cecile Combeau +3 more 2008-12-30
7211592 Substituted an unsubstituted benzooxathiazoles and compounds derived therefrom Stefan Petry, Karl-Heinz Baringhaus, Guenter Mueller 2007-05-01
6566390 Substituted and unsubstituted benzooxathiazoles and compounds derived therefrom Stefan Petry, Karl-Heinz Baringhaus, Guenter Mueller 2003-05-20